Search Results

There are 7032 results for: content related to: Bevacizumab in ophthalmology: the controversy moves forward

  1. You have free access to this content
    Anti-vascular endothelial growth factor for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Sharon D Solomon, Kristina Lindsley, Satyanarayana S Vedula, Magdalena G Krzystolik and Barbara S Hawkins

    Published Online : 29 AUG 2014, DOI: 10.1002/14651858.CD005139.pub3

  2. You have free access to this content
    Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Lorenzo Moja, Ersilia Lucenteforte, Koren H Kwag, Vittorio Bertele, Annalisa Campomori, Usha Chakravarthy, Roberto D'Amico, Kay Dickersin, Laurent Kodjikian, Kristina Lindsley, Yoon Loke, Maureen Maguire, Daniel F Martin, Alessandro Mugelli, Bernd Mühlbauer, Isabel Püntmann, Barnaby Reeves, Chris Rogers, Christine Schmucker, Manju L Subramanian and Gianni Virgili

    Published Online : 15 SEP 2014, DOI: 10.1002/14651858.CD011230.pub2

  3. Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model

    Journal of Evaluation in Clinical Practice

    Volume 18, Issue 2, April 2012, Pages: 247–255, Jignesh J. Patel, Margaret A.S. Mendes, Mark Bounthavong, Melissa L.D. Christopher, Daniel Boggie and Anthony P. Morreale

    Version of Record online : 16 SEP 2010, DOI: 10.1111/j.1365-2753.2010.01546.x

  4. You have free access to this content
    Anti-vascular endothelial growth factor for diabetic macular oedema

    Intervention Review

    The Cochrane Library

    Gianni Virgili, Mariacristina Parravano, Francesca Menchini and Jennifer R Evans

    Published Online : 24 OCT 2014, DOI: 10.1002/14651858.CD007419.pub4

  5. Retina, Vitreous

    Clinical & Experimental Ophthalmology

    Volume 36, Issue s1, June 2008, Pages: A459–A584,

    Version of Record online : 18 JUL 2008, DOI: 10.1111/j.1442-9071.2008.01760.x

  6. Characterization of human sclera barrier properties for transscleral delivery of bevacizumab and ranibizumab

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 3, March 2013, Pages: 892–903, He Wen, Jinsong Hao and S. Kevin Li

    Version of Record online : 4 DEC 2012, DOI: 10.1002/jps.23387

  7. You have free access to this content
    The ABCs of RVO: A review of retinal venous occlusion

    Clinical and Experimental Optometry

    Volume 97, Issue 4, July 2014, Pages: 311–323, Derek MacDonald

    Version of Record online : 20 NOV 2013, DOI: 10.1111/cxo.12120

  8. You have free access to this content
    Anti-vascular endothelial growth factor for myopic choroidal neovascularization

    Clinical & Experimental Ophthalmology

    Volume 40, Issue 1, January/February 2012, Pages: e98–e110, Danny S Ng, Alvin KH Kwok and Clement W Chan

    Version of Record online : 5 FEB 2012, DOI: 10.1111/j.1442-9071.2011.02684.x

  9. You have free access to this content
    Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

    Intervention Review

    The Cochrane Library

    Maria José Martinez-Zapata, Arturo J Martí-Carvajal, Ivan Solà, José I Pijoán, José A Buil-Calvo, Josep A Cordero and Jennifer R Evans

    Published Online : 24 NOV 2014, DOI: 10.1002/14651858.CD008721.pub2

  10. You have free access to this content
    Bevacizumab modulates epithelial-to-mesenchymal transition in the retinal pigment epithelial cells via connective tissue growth factor up-regulation

    Acta Ophthalmologica

    Volume 90, Issue 5, August 2012, Pages: e389–e398, Ching-Long Chen, Chang-Min Liang, Yi-Hao Chen, Ming-Cheng Tai, Da-Wen Lu and Jiann-Torng Chen

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1755-3768.2012.02426.x

  11. You have free access to this content
    Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion

    Intervention Review

    The Cochrane Library

    Tasanee Braithwaite, Afshan A Nanji, Kristina Lindsley and Paul B Greenberg

    Published Online : 1 MAY 2014, DOI: 10.1002/14651858.CD007325.pub3

  12. Bevacizumab and ranibizumab on microvascular endothelial cells: A comparative study

    Journal of Cellular Biochemistry

    Volume 108, Issue 6, 15 December 2009, Pages: 1410–1417, Raquel Costa, Ângela Carneiro, Ana Rocha, Ana Pirraco, Manuel Falcão, Luísa Vasques and Raquel Soares

    Version of Record online : 26 OCT 2009, DOI: 10.1002/jcb.22378

  13. You have free access to this content
    Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration

    Acta Ophthalmologica

    Volume 92, Issue 8, December 2014, Pages: 713–723, Geoffrey K. Broadhead, Thomas Hong and Andrew A. Chang

    Version of Record online : 12 JUN 2014, DOI: 10.1111/aos.12463

  14. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion

    Intervention Review

    The Cochrane Library

    Danny Mitry, Catey Bunce and David Charteris

    Published Online : 31 JAN 2013, DOI: 10.1002/14651858.CD009510.pub2

  15. You have free access to this content
    Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future

    British Journal of Clinical Pharmacology

    Volume 78, Issue 4, October 2014, Pages: 699–706, Tsong Qiang Kwong and Moin Mohamed

    Version of Record online : 19 SEP 2014, DOI: 10.1111/bcp.12371

  16. Safety, sterility and stability of direct-from-vial multiple dosing intravitreal injection of bevacizumab

    Clinical & Experimental Ophthalmology

    Volume 43, Issue 5, July 2015, Pages: 466–473, Taraprasad Das, Srinivas Volety, Saad M Ahsan, Abhay K Thakur, Savitri Sharma, Tapas R Padhi, Soumyava Basu and Ch Mohan Rao

    Version of Record online : 14 APR 2015, DOI: 10.1111/ceo.12489

  17. You have free access to this content
    Response to Replacing ranibizumab with bevacizumab on the Pharmaceutical Benefits Scheme: where does the current evidence leave us?

    Clinical and Experimental Optometry

    Volume 95, Issue 5, September 2012, Pages: 541–543, John G O'Shea

    Version of Record online : 5 JUN 2012, DOI: 10.1111/j.1444-0938.2012.00736.x

  18. Age-Related Macular Degeneration

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 8, August 2013, Pages: 838–855, Lily K. Cheung and Angie Eaton

    Version of Record online : 11 APR 2013, DOI: 10.1002/phar.1264

  19. Submacular haemorrhage after intravitreal bevacizumab compared with intravitreal ranibizumab in large occult choroidal neovascularization

    Clinical & Experimental Ophthalmology

    Volume 37, Issue 4, May/June 2009, Pages: 384–388, Radhika Krishnan, Srinivas Goverdhan and Jonathan Lochhead

    Version of Record online : 6 APR 2009, DOI: 10.1111/j.1442-9071.2009.02043.x

  20. Aflibercept for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Salman Sarwar, Elizabeth Clearfield, Mohamed Kamel Soliman, Mohammad Ali Sadiq, Andrew J Baldwin, Mostafa Hanout, Aniruddha Agarwal, Yasir J Sepah, Diana V Do and Quan Dong Nguyen

    Published Online : 8 FEB 2016, DOI: 10.1002/14651858.CD011346.pub2